Flovent Rotadisk

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.


Approval Status:

Approved November 1997

Specific Treatments:


Find Related Trials for The Following Conditions

General Information

Flovent Rotadisk, a fluticasone inhalation powder, has been approved for the maintenance treatment of asthma in patients four and older. The corticosteroid is dosed twice daily and is available in strengths of 50 mcg and 100 mcg for children and adults and in a 250 mcg for adults.